Skip to main content
Premium Trial:

Request an Annual Quote

For a Good Cause

23andme is expanding its 23andWe initiative, which aims to acquire detailed health and trait data from existing customers, by recruiting 10,000 Parkinson's disease patients for a targeted analysis of the genetic and environmental causes of this disease. The program, backed in part by the Michael J. Fox Foundation, was announced on the 23andMe blog. Parkinson's patients get access to the full features of a 23andMe genome scan for $25 in return for participation in online surveys. "I think the model of participant-driven research is a novel and powerful one, that will increasingly come to dominate the genomic research landscape," according to blogger Daniel MacArthur.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.